Marshall Wace’s Tenaya Therapeutics TNYA Stock Holding History

Marshall Wace’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.87M	Buy	2,705,390 +1,299,355	+92%	+$959K	﹤0.01%	1828
2025 Q4	$998K	Buy	1,406,035 +1,388,750	+8,034%	+$1.89M	﹤0.01%	1930
2025 Q3	$28K	Sell	17,285 -130,804	-88%	-$132K	﹤0.01%	2769
2025 Q2	$90.3K	Buy	+148,089	New	+$75.4K	﹤0.01%	2554
2024 Q4	–	Sell	-158,057	Closed	-$305K	–	3010
2024 Q3	$305K	Buy	+158,057	New	+$446K	﹤0.01%	2135
2024 Q1	–	Sell	-18,941	Closed	-$61.4K	–	2802
2023 Q4	$61.4K	Buy	+18,941	New	+$40.9K	﹤0.01%	2069
2023 Q3	–	Sell	-84,181	Closed	-$494K	–	2682
2023 Q2	$494K	Buy	+84,181	New	+$489K	﹤0.01%	1993
2022 Q4	–	Sell	-88,811	Closed	-$258K	–	3428
2022 Q3	$258K	Buy	+88,811	New	+$414K	﹤0.01%	2998

Other funds holding TNYA

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BGM

Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $141M AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Marshall Wace's TNYA Position: Q1 2026 in Review

Marshall Wace increased its Tenaya Therapeutics (TNYA) stake by 92% in Q1 2026, buying an estimated $959K and bringing the position to 2,705,390 shares worth $1.87M. The position accounts for ﹤0.01% of the portfolio, ranked #1828.

Marshall Wace first reported a position in TNYA in Q3 2022 and has held it in 8 quarters since. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

Marshall Wace held 2,705,390 shares of Tenaya Therapeutics worth $1.87M as of Q1 2026.
Marshall Wace bought 1,299,355 Tenaya Therapeutics shares in Q1 2026, an estimated $959K.
Tenaya Therapeutics made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #1828 holding.
Marshall Wace first reported a position in Tenaya Therapeutics in Q3 2022 and has held it in 8 quarters since.
103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.